Detalhe da pesquisa
1.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood
; 2024 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38728380
2.
Sequence not salvage.
Br J Haematol
; 204(5): 1590-1592, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38563345
3.
The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 204(4): 1159-1175, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38390784
4.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38577874
5.
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
Blood
; 140(12): 1408-1418, 2022 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35667047
6.
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38546696
7.
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Am J Hematol
; 99(2): 203-215, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38009469
8.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Eur J Haematol
; 111(2): 181-190, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37082839
9.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36266607
10.
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
Br J Haematol
; 197(1): 82-96, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35166376
11.
Perturbative Quantum Simulation.
Phys Rev Lett
; 129(12): 120505, 2022 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36179156
12.
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 97(5): 562-573, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35132679
13.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
Eur J Haematol
; 106(5): 708-715, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33580608
14.
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry.
Am J Hematol
; 96(10): 1186-1194, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34152630
15.
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
Am J Hematol
; 96(1): 69-79, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33064301
16.
Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development.
Handb Exp Pharmacol
; 265: 57-71, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33367950
17.
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT.
Biol Blood Marrow Transplant
; 26(9): 1559-1566, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32417491
18.
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 190(3): 437-441, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32108327
19.
Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma.
Curr Opin Oncol
; 32(5): 418-426, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32740095
20.
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Haematologica
; 105(2): 297-316, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31753925